Mallinckrodt Reports Results of StrataGraft Regenerative Tissue in P-III STRATA2016 Study for Deep Partial-thickness Thermal Burns

 Mallinckrodt Reports Results of StrataGraft Regenerative Tissue in P-III STRATA2016 Study for Deep Partial-thickness Thermal Burns

Mallinckrodt Reports Results of StrataGraft Regenerative Tissue in P-III STRATA2016 Study for Deep Partial-thickness Thermal Burns

Shots:

  • The P-III STRATA2016 study involves assessing of StrataGraft treatment vs SoC (autograft) in 71 patients with deep partial-thickness thermal burns aged ≥18yrs. across 12 clinical sites in the US
  • The P-III STRATA2016 study resulted in meeting both 1EPs ie, 98% reduction in the area requiring autograft and burn wounds achieved durable wound closure at the treatment site at three months post-placement (83% vs 86%)
  • StrataGraft regenerative tissue is an investigational treatment for reducing autograft in patients with severe thermal burns with its expected BLA submission in H1’20 and is being evaluated in P-II study for full-thickness burns with its anticipated onset of a pediatric study in H2’19

Click here to­ read full press release/ article | Ref: Mallinckrodt | Image: WSJ

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post